Elovl6 is a poor prognostic predictor in breast cancer

  • Authors:
    • Yin‑Hsun Feng
    • Wei‑Yu Chen
    • Yu‑Hsuan Kuo
    • Chao‑Ling Tung
    • Chao‑Jung Tsao
    • Ai‑Li Shiau
    • Chao‑Liang Wu
  • View Affiliations

  • Published online on: May 16, 2016     https://doi.org/10.3892/ol.2016.4587
  • Pages: 207-212
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Elongation of long chain fatty acids family member 6 (Elovl6) has been demonstrated to be involved in insulin resistance, obesity and lipogenesis. In addition, it has been reported that the protein is upregulated in human hepatocellular carcinoma and is implicated in nonalcoholic steatohepatitis-associated liver carcinogenesis. Excess body weight has been associated with an increased risk of postmenopausal breast cancer and poor prognosis. However, the connection between Elovl6 expression and outcome of breast cancer remains uncertain. Therefore, the present study used immunohistochemical analysis to investigate the expression of Elovl6 in breast cancer tissues from patients who had undergone curative mastectomy. Out of a total of 70 patients, 37.1% of patients exhibited positive Elovl6 expression in breast cancer tissue, whilst 62.9% were considered as negative. Positive Elov16 expression correlated with positive lymph node involvement and shorter recurrence‑free survival. However, Elovl6 expression had no association with primary tumor size, lymph node metastasis, stage, grade, estrogen receptor, progesterone receptor, HER2 and age. Therefore, positive Elovl6 expression is a poor prognostic factor in patients with breast cancer that have previously undergone surgery, and may function as a potential therapeutic approach in the future, particularly in the scope of obesity related disease.
View Figures
View References

Related Articles

Journal Cover

July-2016
Volume 12 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Feng YH, Chen WY, Kuo YH, Tung CL, Tsao CJ, Shiau AL and Wu CL: Elovl6 is a poor prognostic predictor in breast cancer. Oncol Lett 12: 207-212, 2016
APA
Feng, Y., Chen, W., Kuo, Y., Tung, C., Tsao, C., Shiau, A., & Wu, C. (2016). Elovl6 is a poor prognostic predictor in breast cancer. Oncology Letters, 12, 207-212. https://doi.org/10.3892/ol.2016.4587
MLA
Feng, Y., Chen, W., Kuo, Y., Tung, C., Tsao, C., Shiau, A., Wu, C."Elovl6 is a poor prognostic predictor in breast cancer". Oncology Letters 12.1 (2016): 207-212.
Chicago
Feng, Y., Chen, W., Kuo, Y., Tung, C., Tsao, C., Shiau, A., Wu, C."Elovl6 is a poor prognostic predictor in breast cancer". Oncology Letters 12, no. 1 (2016): 207-212. https://doi.org/10.3892/ol.2016.4587